DxA Investigator Day 2024
AD/PD Registration Required
DxA Investigator Day will highlight innovative and promising research from several of the Alzheimer’s Drug Discovery Foundation’s (ADDF) scientists funded through the Diagnostics Accelerator (DxA). This full-day symposium aims to facilitate networking and collaboration among our groundbreaking scientists as their research forges the path towards a combination therapy and precision medicine approach to treating Alzheimer’s disease.
Speakers
Discussions
Sessions
Invitation only
Speakers
Associate Professor of Neurochemistry at the Department of Psychiatry and Neurochemistry at the University Gothenburg (Sweden)
Professor of Anatomy & Neurobiology, Neurology and Epidemiology at Boston University Schools of Medicine and Public Health, Senior Fellow at the Institute for Health Systems Innovation and Policy at the Questrom School of Business, and Director of Neuropsychology at the Framingham Heart Study
CEO, Co-Founder & Chairman of The Board of Directors of ADmit Therapeutics
Professor and Academic Chair in Clinical Neurochemistry at University of Gothenburg, and Head of the Clinical Neurochemistry Lab at Sahlgrenska University Hospital (Sweden)
Managing Director of Health & Life Sciences at Gates Ventures
CEO and Co-Founder of C2N Diagnostics
Chief Medical Officer at Altoida
Senior Research Professor of Neurology at Indiana University School of Medicine and Primary Member of Stark Neurosciences Research Institute
Consulting Pathologist at Robert A. Dean Consulting, LLC and Adjunct Associate Professor at Indiana University School of Medicine in the Department of Pathology & Laboratory Medicine
Chief Scientific Officer and Founding Scientist at NeuroDex
Co-Founder and Chief Science Officer at the Alzheimer’s Drug Discovery Foundation (ADDF)
Associate Professor of Ophthalmology at the Duke Eye Center
Chief Scientific Officer at ALZpath
CEO of Altoida
Program Director of SpeechDx, and Co-Founder and Chief Science Officer at Chronicles Health
CEO and Co-Founder of StartUp Health
Professor and Klorfine Family Chair of Ophthalmology at University of Washington
CEO and Co-Founder at ki:elements
Executive Director of Drug Development at the Alzheimer’s Drug Discovery Foundation (ADDF)
CEO of the Alzheimer’s Drug Discovery Foundation (ADDF)
Founder and Chief Scientific Officer at Altoida, and Expert Evaluator for Brain & Mental Health and Digital Biomarkers at EIT Health
Founder and Chief Scientific Officer at Altoida, and Expert Evaluator for Brain & Mental Health and Digital Biomarkers at EIT Health
Professor of Neurochemistry and Chair of the Neurochemistry Lab at Amsterdam UMC
Product Development Manager at Fujirebio Europe NV
Business Segment and Discipline Director of Neurology at Labcorp
Science Director of Neuropsychology Business Development at Cogstate
Professor of Neurochemistry at the University of Gothenburg (Sweden) and University College London (UK), and a Clinical Chemist at Sahlgrenska University Hospital (Sweden)
Agenda At-A-Glance
Morning Session
Afternoon Session
At the Lisbon Congress Centre
Lisbon, Portugal
Praça das Indústrias 1, 1300-307 Lisboa, Portugal
This year’s DxA Investigator Day will take place at the Lisbon Congress Centre (CCL).
Registration Location: Level 1 | Auditorium II